Oral metabolism and efficacy of Kalanchoe pinnata flavonoids in a murine model of cutaneous leishmaniasis

Planta Medica

Volumn 75, Issue 4, 2009, Pages 307-311

  Muzitano, Michelle F ^a,c   Falcão, Camila A B ^a   Cruz, Elaine A ^a   Bergonzi, Maria C ^b   Bilia, Anna R ^b   Vincieri, Franco F ^b   Rossi Bergmann, Bartira ^a   Costa, Sônia S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

Author keywords

Crassulaceae; HPLC DAD MS; Kalanchoe pinnata; Leishmaniasis; Metabolism; Quercetin glycosides

Indexed keywords

ANTIPARASITIC AGENT; KALANCHOE PINNATA EXTRACT; PLANT EXTRACT; QUERCETIN; QUERCETIN 3 O ALPHA LEVO ARABINOPYRANOSYL (1-2) ALPHA LEVO RHAMNOPYRANOSIDE; QUERCETIN 3 O ALPHA LEVO RHAMNOPYRANOSIDE; QUERCETIN DERIVATIVE; QUERCITRIN; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; DRUG DERIVATIVE; FLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KALANCHOE; LEISHMANIA; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SKIN LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; ORAL DRUG ADMINISTRATION;

CRASSULACEAE; KALANCHOE PINNATA; LEISHMANIA AMAZONENSIS; MURINAE; MUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIPROTOZOAL AGENTS; FLAVONES; KALANCHOE; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; QUERCETIN;

EID: 65649100399     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0028-1088382     Document Type: Article

References (26)

1. World Health Organization, Division of Control of Tropical Diseases. http://www.who.int/tdr/diseases/leish/diseaseinfo (accessed in 2008)
2. Croft SL, Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Des 2002; 8: 319-342
3. Da Silva SAG, Costa SS, Rossi-Bergmann B. The anti-leishmanial effect of Kalanchoe is mediated by nitric oxide intermediates. Parasitology 1999; 118: 575-582
4. Da Silva SAG, Costa SS, Mendonça SCF, Silva EM, Moraes VLG, Rossi- Bergmann B. Therapeutic effect of oral Kalanchoe pinnata leaf extract in murine leishmaniasis. Acta Trop 1995; 60: 201-205
5. Torres-Santos EC, Da Silva SAG, Costa SS, Santos APPT, Almeida AP, Rossi-Bergmann B. Toxicological analysis and effectiveness of oral Kalanchoe pinnata on a human case of cutaneous leishmaniasis. Phytother Res 2003; 17: 801-803
6. Muzitano MF, Cruz EA, Almeida AP, Silva SAG, Kaiser CR, Guette C et al. Quercitrin: An antileishmanial flavonoid glycoside from Kalanchoe pinnata. Planta Med 2006; 72: 81-83
7. Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi-Bergmann B, Costa SS. Assessment of antileishmanial activity of new and unusual flavonoids from Kalanchoe pinnata. Phytochemistry 2006; 67: 2071-2077
8. Demicheli C, Ochoa R, Silva JBB, Falcão CAB, Rossi-Bergmann B, Melo AL et al. Oral delivery of meglumine antimoniate using beta-cyclodextrin for the treatment of leishmaniasis. Antimicrob Agents Chemother 2004; 48: 100-103 (Pubitemid 38040183)
9. Rossi-Bergmann B, Falcão CAB, Lenglet A, Santos CRB, Pinto DC, Traub- Cseko Y. A simple fluorimetric method for assessing drug and vaccine efficacy in cutaneous leishmaniasis using Leishmania amazonensis expressing green fluorescence protein. Mem Inst Oswaldo Cruz 1999; 94: 74
10. Rossi-Bergmann B, Costa SS, Borges MBS, Da Silva SAG, Noleto GR, Souza MLM et al. Immunosuppressive effect of the aqueous extract of Kalanchoe pinnata in mice. Phytother Res 1994; 8: 399-402
11. Pal S, Chaudhuri AKN. Anti-inflammatory action of Bryophyllum pinnatum leaf extract. Fitoterapia 1990; 6: 527-533
12. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673-751
13. Mittra B, Saha A, Chowdhury AR, Pal C, Mandal S, Mukhopadhyay S et al. Luteolin, an abundant dietary component is a potent antileishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol Med 2000; 6: 527-541
14. Sen G, Mandal S, Roy SS, Mukhopadhyay S, Biswas T. Therapeutic use of quercetin in the control of infection and anemia associated with visceral leishmaniasis. Free Radic Biol Med 2005; 38: 1257-1264 (Pubitemid 40445542)
15. Sarkar S, Mandal S, Sinha J, Mukhopadhyay S, Das N, Basu MK. Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes. J Drug Target 2002; 10: 573-578
16. Sen G, Mukhopadhyay S, Ray M, Biswas T. Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J Antimicrob Chemother 2008; 61: 1066-1075
17. Jean-Moreno V, Rojas R, Goyeneche D, Coombs GH,Walker J. Leishmania donovani: Differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp Parasitol 2006; 112: 21-30 (Pubitemid 41796476)
18. Tasdemir D, Kaiser M, Brun R, Yardley V, Schmidt TJ, Tosun F et al. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 2006; 50: 1352-1364
19. Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med 2004; 36: 829-837
20. O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003; 65: 479-491
21. Day AJ, Bao Y, Morgan MRA, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 2000; 29: 1234-1243
22. Day AJ, Gee JM, Dupont MS, Johnson IT, Williamson G. Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol 2003; 65: 1199-1206 (Pubitemid 36349759)
23. Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000; 56: 545-553
24. Prasain JK, Wang CC, Barnes S. Mass spectrometric methods for the determination of flavonoids in biological samples. Free Radic Biol Med 2004; 37: 1324-1350 (Pubitemid 39349236)
25. Wang L, Morris ME. Liquid chromatography-tandem mass spectroscopy assay for quercetin and conjugated quercetin metabolites in human plasma and urine. J Chromatogr B 2005; 821: 194-201 (Pubitemid 40827027)
26. Spencer JPE, El Mohsen MMA, Rice-Evans C. Cellular uptake andmetabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 2004; 423: 148-161 (Pubitemid 38198224)